Publicaciones en colaboración con investigadores/as de University of Naples Federico II (25)

2023

  1. Idiopathic Thrombocytopaenic Purpura associated with Inflammatory Bowel Disease: a multicentre ECCO CONFER case series

    Journal of Crohn's and Colitis, Vol. 17, Núm. 5, pp. 722-727

2022

  1. Outcome of liver cancer patients with SARS-CoV-2 infection: An International, Multicentre, Cohort Study

    Liver International, Vol. 42, Núm. 8, pp. 1891-1901

2021

  1. Strategy to prevent epitope masking in CAR.CD19+ B-cell leukemia blasts

    Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 6

  2. Total body irradiation + fludarabine compared to busulfan + fludarabine as “reduced-toxicity conditioning” for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation in first complete remission: a study by the Acute Leukemia Working Party of the EBMT

    Bone Marrow Transplantation, Vol. 56, Núm. 2, pp. 481-491

2019

  1. Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)

    European Journal of Immunology, Vol. 49, Núm. 10, pp. 1457-1973

2018

  1. Seroepidemiological survey of human exposure to Dirofilaria spp. in Romania and Moldova

    Acta Tropica, Vol. 187, pp. 169-174

2017

  1. Does renal function affect the efficacy or safety of a pharmacoinvasive strategy in patients with ST-elevation myocardial infarction? A meta-analysis

    American Heart Journal, Vol. 193, pp. 46-54

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

2015

  1. Consistency of benefit from an early invasive strategy after fibrinolysis: A patient-level meta-analysis

    Heart, Vol. 101, Núm. 19, pp. 1554-1561

  2. Relationship between time to invasive assessment and clinical outcomes of patients undergoing an early invasive strategy after fibrinolysis for ST-segment elevation myocardial infarction: A patient-level analysis of the randomized early routine invasive clinical trials

    JACC: Cardiovascular Interventions, Vol. 8, Núm. 1, pp. 166-174

2014

  1. Research update for articles published in EJCI in 2012

    European Journal of Clinical Investigation, Vol. 44, Núm. 10, pp. 1010-1023

  2. Routine invasive management early after fibrinolysis: Relationship between baseline risk and treatment effects in a pooled patient-level analysis of 7 randomized controlled trials

    American Heart Journal, Vol. 168, Núm. 5, pp. 757-765.e3

2013

  1. Common susceptibility alleles and SQSTM1 mutations predict disease extent and severity in a multinational study of patients with Paget's disease

    Journal of Bone and Mineral Research, Vol. 28, Núm. 11, pp. 2338-2346

2012

  1. Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: A consensus proposal

    International Archives of Allergy and Immunology, Vol. 157, Núm. 3, pp. 215-225

  2. European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives

    Wiener Klinische Wochenschrift, Vol. 124, Núm. 23-24, pp. 807-814

  3. Guidelines for the use and interpretation of assays for monitoring autophagy

    Autophagy, Vol. 8, Núm. 4, pp. 445-544

2011

  1. Genome-wide association identifies three new susceptibility loci for Paget's disease of bone

    Nature Genetics

2010

  1. Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: A meta-analysis

    European Heart Journal, Vol. 31, Núm. 17, pp. 2156-2169

2007

  1. RET/papillary thyroid carcinoma oncogenic signaling through the Rap1 small GTPase

    Cancer Research, Vol. 67, Núm. 1, pp. 381-390